Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical electroencephalographic variables suggesting extrapyramidal side effect risk.

F A Struve1

  • 1Louisiana State University Medical Center, Shreveport 71130.

Clinical EEG (Electroencephalography)
|October 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does EEG predict response to valproate versus lithium in patients with mania?

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2001
Same author

Inadequacies of self-report data for exclusion criteria detection in marihuana research: an empirical case for multi-method direct examination screening.

Journal of addictive diseases·2000
Same author

Topographic quantitative analysis of the intrinsic alpha rhythm in chronic obstructive pulmonary disease.

Clinical EEG (electroencephalography)·2000
Same author

Reduction of auditory P50 gating response in marihuana users: further supporting data.

Clinical EEG (electroencephalography)·2000
Same author

Auditory and visual P300 cognitive evoked responses in patients with COPD: relationship to degree of pulmonary impairment.

Clinical EEG (electroencephalography)·1999
Same author

Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects.

Drug and alcohol dependence·1999

Psychiatric patients with paroxysmal EEG dysrhythmias show higher rates of extrapyramidal symptoms (EPS) when treated with neuroleptics. These EEG patterns may indicate a higher risk for adverse drug reactions.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Electrophysiology

Background:

  • Previous research linked paroxysmal electroencephalogram (EEG) dysrhythmias in psychiatric patients to various side effects.
  • These side effects include dyskinetic movements, extrapyramidal symptoms (EPS), iatrogenic seizures, and oral contraceptive-related effects.

Purpose of the Study:

  • To investigate the association between paroxysmal EEG dysrhythmias and the occurrence of EPS in neuroleptic-treated psychiatric patients.
  • To determine if EEG patterns predict EPS risk independently of anti-EPS medication.

Main Methods:

  • Analysis of EEG studies (awake and asleep) from 375 neuroleptic-treated psychiatric patients.
  • Comparison of EPS incidence between patients with and without paroxysmal EEG dysrhythmias.

Related Experiment Videos

  • Assessment of anti-EPS medication use and direct examination for EPS signs.

    • Main Results:

    • Patients with minor paroxysmal EEG dysrhythmias were more likely to receive anti-EPS medication.
    • Neuroleptic-treated patients with paroxysmal dysrhythmias showed significantly increased EPS compared to those with normal EEGs, irrespective of anti-EPS medication.
    • The study did not permit individual patient risk prediction.

    Conclusions:

    • Paroxysmal EEG dysrhythmias are associated with a higher incidence of EPS in neuroleptic-treated psychiatric patients.
    • EEG patterns may serve as a biomarker for increased susceptibility to neuroleptic-induced side effects.
    • Future research should consider stratifying samples based on EEG patterns for studying pharmacological side effects.